Colorectal Cancer Trial, Recruiting NCT05529615 Sponsor: Peking University Cancer Hospital & Institute Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT05529615
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are between 18 and 75 years old
  • You have been diagnosed with colon cancer (a specific type called adenocarcinoma) confirmed by a tissue sample test
  • After surgery, your cancer was found to be at a stage II with certain higher-risk features, or stage III — stage II with high-risk features means at least one of the following applies: the tumor had grown into nearby structures (T4), fewer than 12 lymph nodes were checked during surgery, the cancer cells looked very abnormal under a microscope (except in certain cases), the cancer had spread into nearby blood vessels or nerves, or the bowel was blocked or had a tear
  • Scans and surgery confirmed the cancer had not spread to other parts of the body
  • You are reasonably active and able to care for yourself (confirm with trial site)
  • Your cancer has specific test results: MSS/pMMR type and BRAF wild type (confirm with trial site for explanation)
  • Chemotherapy would start within 2 months of your surgery
  • Your heart, liver, kidneys, and other organs are working well enough
  • Your blood test results meet certain minimum levels for red blood cells, white blood cells, platelets, liver enzymes, and kidney function (confirm with trial site for exact values)
  • You, or a family member, understand the study and are willing to sign a consent form

Who may not be able to join:

  • You received chemotherapy, radiotherapy, or immunotherapy before your surgery
  • You have had another cancer diagnosis in the past 5 years (some fully cured skin or cervical cancers may be exceptions — confirm with trial site)
  • You are pregnant
  • You have a serious mental health condition
  • Your general health is too poor to complete a course of chemotherapy
  • You, or your family, are unable to understand the purpose and conditions of the study

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Peking University Cancer Hospital & Institute
Registry
ClinicalTrials.gov
Start date
1 November 2022
Est. completion
1 May 2029

Where this trial is recruiting

🇨🇳 China

Primary endpoints

3-year disease-free survival rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov